- Home
- ZURA vs BARK Comparison
ZURA vs BARK Comparison
Compare ZURA & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- BARK
- Stock Information
- Founded
- ZURA 2022
- BARK 2011
- Country
- ZURA United States
- BARK United States
- Employees
- ZURA N/A
- BARK N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- BARK Department/Specialty Retail Stores
- Sector
- ZURA Health Care
- BARK Consumer Discretionary
- Exchange
- ZURA Nasdaq
- BARK Nasdaq
- Market Cap
- ZURA 69.9M
- BARK 244.9M
- IPO Year
- ZURA N/A
- BARK N/A
- Fundamental
- Price
- ZURA $1.13
- BARK $0.91
- Analyst Decision
- ZURA Buy
- BARK Strong Buy
- Analyst Count
- ZURA 7
- BARK 3
- Target Price
- ZURA $14.33
- BARK $2.50
- AVG Volume (30 Days)
- ZURA 709.5K
- BARK 2.4M
- Earning Date
- ZURA 08-08-2025
- BARK 08-06-2025
- Dividend Yield
- ZURA N/A
- BARK N/A
- EPS Growth
- ZURA N/A
- BARK N/A
- EPS
- ZURA N/A
- BARK N/A
- Revenue
- ZURA N/A
- BARK $484,182,000.00
- Revenue This Year
- ZURA N/A
- BARK N/A
- Revenue Next Year
- ZURA N/A
- BARK $9.47
- P/E Ratio
- ZURA N/A
- BARK N/A
- Revenue Growth
- ZURA N/A
- BARK N/A
- 52 Week Low
- ZURA $0.97
- BARK $0.77
- 52 Week High
- ZURA $5.07
- BARK $2.56
- Technical
- Relative Strength Index (RSI)
- ZURA 48.73
- BARK 44.67
- Support Level
- ZURA $1.00
- BARK $0.84
- Resistance Level
- ZURA $1.22
- BARK $0.94
- Average True Range (ATR)
- ZURA 0.08
- BARK 0.05
- MACD
- ZURA -0.00
- BARK 0.02
- Stochastic Oscillator
- ZURA 52.00
- BARK 83.94
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.